Executive Summary
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Undervalued with proven track record and pays a dividend.
Similar Companies
Share Price & News
How has AXA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CS's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
2.0%
CS
2.2%
FR Insurance
2.3%
FR Market
1 Year Return
-20.5%
CS
-27.3%
FR Insurance
-8.7%
FR Market
Return vs Industry: CS exceeded the French Insurance industry which returned -27.3% over the past year.
Return vs Market: CS underperformed the French Market which returned -8.7% over the past year.
Shareholder returns
| CS | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.0% | 2.2% | 2.3% |
| 30 Day | -5.7% | -7.6% | -3.1% |
| 90 Day | 28.0% | 25.4% | 16.3% |
| 1 Year | -20.5%-20.5% | -27.3%-27.3% | -7.1%-8.7% |
| 3 Year | -15.4%-24.4% | -20.9%-28.8% | 11.2%2.1% |
| 5 Year | 1.4%-17.9% | -2.1%-20.2% | 28.6%11.4% |
Price Volatility Vs. Market
How volatile is AXA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
Read This Before Considering AXA SA (EPA:CS) For Its Upcoming €0.73 Dividend4 weeks ago | Simply Wall St
Those Who Purchased AXA (EPA:CS) Shares Three Years Ago Have A 17% Loss To Show For It1 month ago | Simply Wall St
How Should Investors React To AXA SA's (EPA:CS) CEO Pay?Valuation
Is AXA undervalued compared to its fair value and its price relative to the market?
34.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CS (€18.9) is trading below our estimate of fair value (€28.75)
Significantly Below Fair Value: CS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CS is poor value based on its PE Ratio (12.5x) compared to the Insurance industry average (10.1x).
PE vs Market: CS is good value based on its PE Ratio (12.5x) compared to the French market (15x).
Price to Earnings Growth Ratio
PEG Ratio: CS is good value based on its PEG Ratio (0.6x)
Price to Book Ratio
PB vs Industry: CS is good value based on its PB Ratio (0.6x) compared to the FR Insurance industry average (0.7x).
Next Steps
Future Growth
How is AXA forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
21.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CS's forecast earnings growth (21.6% per year) is above the savings rate (0.6%).
Earnings vs Market: CS's earnings (21.6% per year) are forecast to grow faster than the French market (13.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CS's revenue is expected to decline over the next 3 years (-6.6% per year).
High Growth Revenue: CS's revenue is forecast to decline over the next 3 years (-6.6% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CS's Return on Equity is forecast to be low in 3 years time (9.9%).
Next Steps
Past Performance
How has AXA performed over the past 5 years?
-12.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CS has high quality earnings.
Growing Profit Margin: CS's current net profit margins (2.7%) are higher than last year (1.8%).
Past Earnings Growth Analysis
Earnings Trend: CS's earnings have declined by -12.7% per year over the past 5 years.
Accelerating Growth: CS's earnings growth over the past year (91.9%) exceeds its 5-year average (-12.7% per year).
Earnings vs Industry: CS earnings growth over the past year (91.9%) exceeded the Insurance industry 57.5%.
Return on Equity
High ROE: CS's Return on Equity (5%) is considered low.
Next Steps
Financial Health
How is AXA's financial position?
Financial Position Analysis
Short Term Liabilities: CS's short term assets (€119.8B) do not cover its short term liabilities (€206.5B).
Long Term Liabilities: CS's short term assets (€119.8B) do not cover its long term liabilities (€491.2B).
Debt to Equity History and Analysis
Debt Level: CS's debt to equity ratio (72%) is considered high.
Reducing Debt: CS's debt to equity ratio has increased from 46.4% to 72% over the past 5 years.
Debt Coverage: CS's debt is not well covered by operating cash flow (14.8%).
Interest Coverage: CS's interest payments on its debt are well covered by EBIT (8.3x coverage).
Balance Sheet
Next Steps
Dividend
What is AXA current dividend yield, its reliability and sustainability?
3.86%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CS's dividend (3.86%) is higher than the bottom 25% of dividend payers in the French market (1.67%).
High Dividend: CS's dividend (3.86%) is low compared to the top 25% of dividend payers in the French market (4.84%).
Stability and Growth of Payments
Stable Dividend: CS's dividend payments have been volatile in the past 10 years.
Growing Dividend: CS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (48.3%), CS's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CS's dividends in 3 years are forecast to be covered by earnings (53.9% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.5yrs
Average management tenure
CEO
Thomas Buberl (47yo)
3.83yrs
Tenure
€5,088,102
Compensation
Dr. Thomas Buberl, Ph.D. has been Independent Director of International Business Machines Corporation since April 28, 2020. Dr. Buberl served as Chairman of the Board at AXA Equitable Holdings, Inc., since ...
CEO Compensation Analysis
Compensation vs Market: Thomas's total compensation ($USD5.72M) is above average for companies of similar size in the French market ($USD3.89M).
Compensation vs Earnings: Thomas's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.83yrs | €5.09m | 0.013% €6.1m | |
| Chief Integration Officer & Employee Shareholders' Representative Director | 8.25yrs | €110.76k | 0.00076% €342.8k | |
| Group Chief Financial Officer | 0.50yr | no data | no data | |
| Chief Operating Officer | 2.58yrs | no data | no data | |
| Chief Risk & Investment Officer | 0.83yr | no data | no data | |
| Head of Group Corporate Finance & Treasury | no data | no data | no data | |
| Group Chief Information Officer | 2.5yrs | no data | no data | |
| Senior VP & Head of Investor Relations | 6.5yrs | no data | no data | |
| Group General Counsel & Director | 0.083yr | no data | no data | |
| Group Head of Communications | 1.33yrs | no data | no data |
2.5yrs
Average Tenure
55yo
Average Age
Experienced Management: CS's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.83yrs | €5.09m | 0.013% €6.1m | |
| Chief Integration Officer & Employee Shareholders' Representative Director | 8.25yrs | €110.76k | 0.00076% €342.8k | |
| Group General Counsel & Director | 0.083yr | no data | no data | |
| Chairman & CEO of AXA France | 2.08yrs | no data | no data | |
| Honorary Chairman | 10.25yrs | no data | no data | |
| Chairman of the Board | 3.83yrs | no data | 0.066% €29.8m | |
| Independent Director | 11.25yrs | €180.72k | 0.00047% €212.0k | |
| Senior Independent Director | 1.25yrs | €176.42k | 0.00038% €171.4k | |
| Chairman of AXA Canada Operations | no data | no data | no data | |
| Independent Director | 4.25yrs | €127.59k | 0.00028% €126.3k |
3.8yrs
Average Tenure
66yo
Average Age
Experienced Board: CS's board of directors are considered experienced (3.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
AXA SA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: AXA SA
- Ticker: CS
- Exchange: ENXTPA
- Founded: 1852
- Industry: Multi-line Insurance
- Sector: Insurance
- Market Cap: €45.112b
- Shares outstanding: 2.39b
- Website: https://www.axa.com
Number of Employees
Location
- AXA SA
- 25, avenue Matignon
- Paris
- Ile-de-France
- 75008
- France
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AXAH.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Jan 1980 |
| CS | ENXTPA (Euronext Paris) | Yes | Ordinary Shares | FR | EUR | Jan 1980 |
| AXA | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Jan 1980 |
| CS | SWX (SIX Swiss Exchange) | Yes | Ordinary Shares | CH | CHF | Jan 1980 |
| 0HAR | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | EUR | Jan 1980 |
| AXA | BIT (Borsa Italiana) | Yes | Ordinary Shares | IT | EUR | Jan 1980 |
| AXA | XTRA (XETRA Trading Platform) | Yes | Ordinary Shares | DE | EUR | Jan 1980 |
| CSP | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | Jan 1980 |
| AXA N | BMV (Bolsa Mexicana de Valores) | Yes | Ordinary Shares | MX | MXN | Jan 1980 |
| CS | WBAG (Wiener Boerse AG) | Yes | Ordinary Shares | AT | EUR | Jan 1980 |
| AXAH.Y | OTCPK (Pink Sheets LLC) | ADS-EACH REP 1 ORD EUR2.29 | US | USD | Jun 1996 | |
| AXAA | DB (Deutsche Boerse AG) | ADS-EACH REP 1 ORD EUR2.29 | DE | EUR | Jun 1996 | |
| CSNV | ENXTPA (Euronext Paris) | EUR2.29 (RFD 01/01/2020) | FR | EUR | Jan 2020 |
Biography
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health. Its products include motor, household, property and general liability insurance, banking, savings vehicles, and other investment-based products for personal/individual and commercial/group customers, as well as health, protection, and retirement products for individual or professional customers. The company also provides term life, whole life, universal life, endowment, and deferred and immediate annuities; medical cover; and other protection and health products, such as disability, cancer, and critical illness. In addition, it offers unit-linked, group term, and hospital cash products and investment products; and coverage against excess and surplus lines, environmental and professional liability, construction, marine, energy, aviation and satellite, fine art and specie, equine, livestock and aquaculture, accident and health and crisis management, and other risks. Further, the company provides casualty, property risk, property catastrophe, specialty, and other reinsurance lines; and individual and group retirement products, and employee benefits. Additionally, it is involved in the provision of investment management services through managed accounts, hedge funds, mutual funds, and other investment vehicles to private clients, as well as fundamental research, quantitative, and brokerage-related services in equities and listed options for institutional investors; management of retail mutual funds for individual investors; and management of investments on behalf of institutional clients. The company was founded in 1852 and is headquartered in Paris, France.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/07/05 20:46 |
| End of Day Share Price | 2020/07/03 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.